Related Experiment Video
Updated: Jun 12, 2025

Mimicking and Manipulating Pancreatic Acinar-to-Ductal Metaplasia in 3-dimensional Cell Culture
Published on: February 11, 2019
Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer
Luis F Flores1, David L Marks1, Renzo E Vera1
1Division of Oncology Research.
Abstract:
For over a century, scientists reported the disruption of normal nuclear shape and size in cancer. These changes have long been used as tools for diagnosis and staging of malignancies. However, to date, the mechanisms underlying these aberrant nuclear phenotypes and their biological significance remain poorly understood. Using a model of pancreatic ductal adenocarcinoma (PDAC), the major histological subtypes of pancreatic cancer, we found that oncogenic mutant KRAS reduces nuclear size. Transcriptomic and protein expression analysis of mutant KRAS-expressing PDAC cells revealed differential levels of several nuclear envelope-associated genes. Further analysis demonstrated the nuclear lamina protein, Emerin (EMD), acted downstream of KRAS to mediate nuclear size reduction in PDAC. Analysis of human PDAC samples showed that increased EMD expression associates with reduced nuclear size. Finally, in vivo genetic depletion of EMD in a mutant KRAS-driven PDAC model resulted in increased nuclear size and a reduced incidence of poorly differentiated PDAC. Thus, our data provide evidence of a potentially novel mechanism underlying nuclear size regulation and its effect in PDAC carcinogenesis.
Insights
Oncogenic mutant KRAS shrinks cancer cell nuclei by regulating Emerin (EMD). Depleting EMD increases nuclear size and reduces poorly differentiated pancreatic cancer, revealing a novel mechanism in PDAC carcinogenesis.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Nuclear shape and size alterations are hallmarks of cancer, historically used for diagnosis and staging.
- The underlying mechanisms and biological significance of aberrant nuclear phenotypes in cancer remain largely unknown.
Purpose of the Study:
- To investigate the mechanisms and biological significance of nuclear size changes in pancreatic ductal adenocarcinoma (PDAC).
- To identify key molecular players regulating nuclear size in PDAC driven by oncogenic KRAS mutations.
Main Methods:
- Utilized a PDAC model to study the effects of mutant KRAS on nuclear size.
- Performed transcriptomic and protein expression analysis to identify differentially expressed genes.
- Investigated the role of nuclear lamina protein Emerin (EMD) downstream of KRAS.
- Analyzed human PDAC samples for EMD expression and nuclear size correlation.
- Conducted in vivo genetic depletion of EMD in a PDAC model.
Main Results:
- Oncogenic mutant KRAS was found to reduce nuclear size in PDAC cells.
- Mutant KRAS expression altered the levels of nuclear envelope-associated genes, with Emerin (EMD) identified as a key mediator of nuclear size reduction.
- Increased EMD expression in human PDAC samples correlated with reduced nuclear size.
- In vivo EMD depletion in a KRAS-driven PDAC model led to increased nuclear size and a decreased incidence of poorly differentiated tumors.
Conclusions:
- Identified a novel mechanism where mutant KRAS-driven Emerin (EMD) expression reduces nuclear size in pancreatic cancer.
- Demonstrated that EMD plays a significant role in regulating nuclear size and differentiation status in PDAC.
- These findings provide new insights into the molecular basis of nuclear morphology changes and their impact on PDAC carcinogenesis.
Related Concept Videos
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Role of ER in the Secretory Pathway
Components of the secretory pathway
About a third of proteins synthesized in the cell are sorted via the secretory route. They shuffle between different compartments in membrane-bound vesicles until they reach their final destination. The main intracellular compartments involved...

